These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7212742)

  • 21. Chronic mucocutaneous candidiasis, from bench to bedside.
    Eyerich K; Eyerich S; Hiller J; Behrendt H; Traidl-Hoffmann C
    Eur J Dermatol; 2010; 20(3):260-5. PubMed ID: 20133219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular pathogenetic mechanisms and immunity in candidiasis].
    Kashkin KP; Kubas' VG
    Vestn Dermatol Venerol; 1982 Jun; (6):22-9. PubMed ID: 6289562
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfer factor (TFd). Part IV. Transfer factor in mucocutaneous candidiasis treatment.
    Miksiewicz-Wasilewska H; Grubek-Jaworska A; Plucińska M; Podsiadło B; Krakówka P; Rzucidło L
    Mater Med Pol; 1981; 13(2):108-12. PubMed ID: 7345253
    [No Abstract]   [Full Text] [Related]  

  • 24. [The endocrine system and candidiasis].
    Bykov VL; Sil'nitskiĭ PA; Karaev ZO; Georgadze ER; Ivanova LA
    Sov Med; 1985; (7):48-52. PubMed ID: 4071235
    [No Abstract]   [Full Text] [Related]  

  • 25. Invasive fungal infections in patients with chronic mucocutaneous candidiasis.
    Kauffman CA; Shea MJ; Frame PT
    Arch Intern Med; 1981 Jul; 141(8):1076-9. PubMed ID: 7247593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and immunologic studies of the use of thymus polypeptide factor (thymostimulin) in chronic mucocutaneous candidiasis].
    Lutz G; Niedecken HW; Bauer R; Kreysel HW
    Hautarzt; 1986 Mar; 37(3):142-5. PubMed ID: 3486176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients.
    Eyerich K; Rombold S; Foerster S; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
    Arch Dermatol Res; 2007 Dec; 299(10):475-81. PubMed ID: 17960405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to normal human melanocytes in vitiligo.
    Naughton GK; Eisinger M; Bystryn JC
    J Exp Med; 1983 Jul; 158(1):246-51. PubMed ID: 6345714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.
    Cui J; Bystryn JC
    Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mucocutaneous candidiasis in exposure to biological agents: a clinical case].
    Magnavita N
    Med Lav; 1993; 84(3):243-8. PubMed ID: 8366837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial chronic mucocutaneous candidiasis. Study of 2 families].
    García-Pérez A; Gómez de la Concha E; Guerra Rodríguez P
    Med Cutan Ibero Lat Am; 1984; 12(1):33-40. PubMed ID: 6330471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of auto-antibodies in chronic mucocutaneous candidiasis without endocrinopathy.
    Zouali M; Drouhet E; Eyquem A
    Mycopathologia; 1984 Feb; 84(2-3):87-93. PubMed ID: 6325916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune system function in candidiasis patients].
    Karaev ZO; Sardyko NV; Lebedeva TN; Pokrovskaia OL; Golikova EA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):63-8. PubMed ID: 3324585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic mucocutaneous candidiasis: a review.
    Nielsen H; Daugaard K; Schiodt M
    Tandlaegebladet; 1985 Oct; 89(18):667-73. PubMed ID: 3913039
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic mucocutaneous candidiasis and systemic lupus erythematosus: a new variant of chronic mucocutaneous candidiasis?
    de Moraes-Vasconcelos D; Domingues-Ferreira M; de Campos Pieri P; da Silva Duarte AJ
    Med Mycol; 2012 May; 50(4):399-403. PubMed ID: 21988702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tested medico-mycological examination methods. III. Immune serological methods for determining fungus (yeast) infections and allergic reactions].
    Friedrich E; Böhme H; Bernhardt H; Böhme H; Friedrich E; Kaben U
    Z Arztl Fortbild (Jena); 1981 Feb; 75(3):132-8. PubMed ID: 7281740
    [No Abstract]   [Full Text] [Related]  

  • 37. Innate and adaptive immunity in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
    Perniola R; Congedo M; Rizzo A; Sticchi Damiani A; Faneschi ML; Pizzolante M; Lobreglio G
    Mycoses; 2008 May; 51(3):228-35. PubMed ID: 18399903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
    Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
    Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic mucocutaneous candidosis.
    Ro BI
    Int J Dermatol; 1988 Sep; 27(7):457-62. PubMed ID: 3065256
    [No Abstract]   [Full Text] [Related]  

  • 40. [Late onset type of chronic mucocutaneous candidiasis---report of 3 cases].
    Zhu YX
    Zhonghua Kou Qiang Ke Za Zhi; 1983 Sep; 18(3):175-6. PubMed ID: 6581030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.